Incyte
INCY
#1116
Rank
โ‚น2.061 T
Marketcap
โ‚น10,321
Share price
0.65%
Change (1 day)
76.63%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): โ‚น650.47

According to Incyte's latest financial reports the company's current EPS (TTM) is โ‚น694.23. In 2025 the company made an earnings per share (EPS) of โ‚น627.66 an increase over its 2024 EPS that were of โ‚น29.48.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น650.473.63%
2025โ‚น627.662029.03%
2024โ‚น29.48-88.39%
2023โ‚น253.9273.38%
2022โ‚น146.45-64.1%
2021โ‚น407.98-408.63%
2020-โ‚น132.19-166.83%
2019โ‚น197.81300%
2018โ‚น49.45-133.33%
2017-โ‚น148.36-378.57%
2016โ‚น53.262700%
2015โ‚น1.90-106.67%
2014-โ‚น28.53-44.44%
2013-โ‚น51.3550%
2012-โ‚น34.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น667.60-3.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น124.58-82.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,684 286.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,377 98.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น599.13-13.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น12.36-101.78%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น55.16-107.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น79.88-111.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น21.87-103.15%๐Ÿ‡บ๐Ÿ‡ธ USA